Joanna Meehan Rhodes

机构：Rutgers, The State University of New Jersey, Johnson University, Environmental and Occupational Health Sciences Institute, Rutgers Cancer Institute · ORCID：0000-0002-5068-9040

发表论文 184 篇 · 总被引 2149 次 · h-index 24

代表论文

• Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study (2025 · Blood · 被引 7)
• Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma (2026 · Blood · 被引 6)
• Pirtobrutinib in Relapsed/Refractory (R/R) Waldenström macroglobulinemia (WM): Up to 5 years of follow-up from the Phase 1/2 BRUIN study (2025 · Blood · 被引 4)
• Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial (2026 · The Lancet Haematology · 被引 3)
• Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study (2026 · Blood Cancer Journal · 被引 2)
• Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study (2026 · Blood Advances · 被引 2)